RSDL Receives European CE Mark

Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 03 Feb 2009 - 0:00 PDT

email to a friend   printer friendly   opinions  

RSDecon, a business of Bracco Diagnostics, Inc., announced that it has received the European CE Mark for its RSDL® Chemical Warfare (CW) agent skin decontamination lotion.

A patented, broad-spectrum liquid CW agent decontaminant, RSDL neutralizes or removes CW agents and T2 toxin from skin on contact, leaving a non-toxic residue that can be rinsed off with water. RSDecon will be demonstrating the product to leading counter terrorism experts and European military commanders and first responders when it participates in the International Defence Exhibition and Conference (IDEX) in Abu Dhabi in February.

Receipt of the CE Mark certifies that RSDL met stringent European Union (EU) medical device requirements, has been labeled safe for its intended use, and can now be circulated freely within the 27 EU members. The U.S. Food and Drug Administration and Australia's Therapeutic Goods Administration have also cleared RSDL.

"The CE mark enables us to more easily put RSDL into the hands of those who truly need it," said Bill Scott, Senior Director of Sales, RSDecon. "As global terrorism continues to rise, accessibility to RSDL is vital for all military personnel and first responders around the world."

Some military organizations and first responders (fire, police and emergency medical organizations including hospitals) already provide their members with RSDL for use in emergency situations involving a CW agent. The U.S. Department of Defense is currently issuing RSDL to combat troops for use in the field. Unlike water or powder-based technologies which can smear or spread the CW agent, RSDL decontaminates or removes these agents from the skin.

In the case of large-scale contamination, RSDL can be self-applied, thus reducing the danger to victims awaiting other procedures. RSDL's single-step application provides the ease of use necessary when time is of the essence.

About RSDecon

RSDecon is a business of Bracco Diagnostics Inc., a U.S. based subsidiary of Milan-based Bracco Imaging S.p.A., a global diagnostic imaging company dedicated to medical imaging agent and solutions development. To learn more about RSDL, visit http://www.RSDecon.com or contact Jeff Jordan, Senior Director of Marketing at Jeff.Jordan@diag.bracco.com.

You can also visit RSDecon at the International Defence Exhibition and Conference (IDEX), 22-26 February at the Abu Dhabi National Exhibition Centre and Global Security Asia, 17-19 March in Singapore.

RSDecon

• Additional
• References
• Citations